Home NDC 64679-929-01 Lisinopril
Product NDC 64679-929
Requested package NDC 64679-929-01
11-digit product format 646790929
Labeler code 64679
Product ID 64679-929_b760b89e-02b4-8439-e053-2a95a90a9de6
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Lisinopril
Dosage form TABLET
Route ORAL
Labeler Wockhardt USA LLC.
Application ANDA078402
Marketing category ANDA
Marketing start 2007-04-19
Marketing end 0000-00-00
Substance LISINOPRIL
Active strength 10 mg/1
Pharmacologic classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A078402-001 LISINOPRIL LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 A078402-002 LISINOPRIL LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 A078402-003 LISINOPRIL LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 A078402-004 LISINOPRIL LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 A078402-005 LISINOPRIL LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 A078402-006 LISINOPRIL LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 252 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078402-005 LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078402-006 LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078402-005 LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078402-006 LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078402-005 LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078402-006 LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078402-005 LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078402-006 LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078402-005 LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078402-006 LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078402-005 LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078402-006 LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 7 · 252 observed states.
FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 64679-929-01 2025-12-23 These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988 64679-929-02 2025-12-23 These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988 64679-929-03 2025-12-23 These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988 64679-929-05 2025-12-23 These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988 64679-929-06 2025-12-23 These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988 64679-929-01 2023-01-30 These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988 64679-929-02 2023-01-30 These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988 64679-929-03 2023-01-30 These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988 64679-929-05 2023-01-30 These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988 64679-929-06 2023-01-30 These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded LISINOPRIL ACTIVE INGREDIENT E7199S1YWR LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 LISINOPRIL ANHYDROUS ACTIVE MOIETY 7Q3P4BS2FD LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 BROWN IRON OXIDE INACTIVE INGREDIENT 1N032N7MFO LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE INACTIVE INGREDIENT O7TSZ97GEP LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 CORN STARCH 3-E-DODECENYL SUCCINIC ANHYDRIDE MODIFIED INACTIVE INGREDIENT QG4MW19XYX LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 MANNITOL INACTIVE INGREDIENT 3OWL53L36A LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 POVIDONES INACTIVE INGREDIENT FZ989GH94E LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 LISINOPRIL ACTIVE INGREDIENT E7199S1YWR LISINOPRIL TABLET [WOCKHARDT USA LLC.] 1 LISINOPRIL ACTIVE MOIETY E7199S1YWR LISINOPRIL TABLET [WOCKHARDT USA LLC.] 1 BROWN IRON OXIDE INACTIVE INGREDIENT 1N032N7MFO LISINOPRIL TABLET [WOCKHARDT USA LLC.] 1 DIBASIC CALCIUM PHOSPHATE DIHYDRATE INACTIVE INGREDIENT O7TSZ97GEP LISINOPRIL TABLET [WOCKHARDT USA LLC.] 1 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 LISINOPRIL TABLET [WOCKHARDT USA LLC.] 1 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT LISINOPRIL TABLET [WOCKHARDT USA LLC.] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 LISINOPRIL TABLET [WOCKHARDT USA LLC.] 1 MANNITOL INACTIVE INGREDIENT 3OWL53L36A LISINOPRIL TABLET [WOCKHARDT USA LLC.] 1 POVIDONE INACTIVE INGREDIENT FZ989GH94E LISINOPRIL TABLET [WOCKHARDT USA LLC.] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 LISINOPRIL TABLET [WOCKHARDT USA LLC.] 1 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ LISINOPRIL TABLET [WOCKHARDT USA LLC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 64679-929 LISINOPRIL TABLET [WOCKHARDT USA LLC.] 5 Legacy NDC 20201227_e927801e-5de4-44f9-b543-789c093de655.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 64679-929-01 64679092901 100 TABLET in 1 BOTTLE (64679-929-01) 100 tablet 2007-04-19 0000-00-00 No No Current